How a premature ejaculation drug sparked a $150 million legal battle over trade secrets
March 23, 2019 at 08:48 AM EDT
The maker of the premature ejaculation drug Promescent is suing consumer giant Reckitt Benckiser for $150 million, alleging fraud and theft of trade secrets. Such lawsuits have grown in popularity since Congress passed a 2016 law making it easier to sue in federal court.
